SA
AFMBX logo
American Funds American Balanced Fund(AFMBX)
Last print 17 weeks agoAbout this dataData status
$38.23▼-0.61 (-1.57%)Stale · 17 weeks old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

American Balanced Fund F-3 (AFMBX)

Days Payables Outstanding

20.89

TTM · Retrieved:

AFMBX logo

AFMBX Days Payables Outstanding

Current (TTM)20.89
AFMBX Days Payables Outstanding (2.64 → 20.89)
Powered by
High-resolution chart · PNG

What is days payables outstanding?

Average days to pay suppliers.

AFMBX days payables outstanding history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

American Balanced Fund F-3 Days Payables Outstanding — Annual fiscal periods
Period endingDays Payables OutstandingChange
20.8887+35.37%
15.4306−10.36%
17.2136+0.49%
17.13−1.34%
17.3635+190.96%
5.9677−18.05%
7.2826−16.73%
8.7455−9.54%
9.6682+23.75%
7.8125+94.39%
4.019+52.04%
2.6433—

Frequently asked questions: AFMBX days payables outstanding

What is American Balanced Fund F-3 (AFMBX)'s current days payables outstanding?

American Balanced Fund F-3 (AFMBX)'s latest reported days payables outstanding (TTM) is 20.89 as of Nov 22, 2026. Average days to pay suppliers.

How much historical days payables outstanding data is available for AFMBX?

Stock Alarm Pro provides 12 dated annual fiscal periods observations for American Balanced Fund F-3 (AFMBX)'s days payables outstanding, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare AFMBX's days payables outstanding to peers or set an alert?

You can open AFMBX's days payables outstanding in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on AFMBX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.